First Patient in Chennai Treated with ABSORB
Abbott has announced that Apollo Hospitals has successfully treated a coronary artery disease patient with the company’s revolutionary ABSORB
New Test Could Predict Efficiency of Hepatitis C Infection Treatment
Scientists at Inserm and Institut Pasteur has developed a prognostic test that can predict the efficacy of hepatitis C treatments has been developed. The commercialisation of the test is expected in 2011.
